Clearline Capital LP Buys Shares of 378,252 Integral Ad Science Holding Corp. (NASDAQ:IAS)

Clearline Capital LP bought a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 378,252 shares of the company's stock, valued at approximately $3,949,000. Clearline Capital LP owned approximately 0.23% of Integral Ad Science at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Jennison Associates LLC boosted its stake in shares of Integral Ad Science by 3.3% during the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock valued at $663,000 after buying an additional 2,046 shares during the period. Oppenheimer & Co. Inc. grew its stake in Integral Ad Science by 8.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock valued at $293,000 after purchasing an additional 2,069 shares in the last quarter. Envestnet Asset Management Inc. increased its position in Integral Ad Science by 7.4% in the 4th quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock worth $332,000 after purchasing an additional 2,188 shares during the last quarter. Arizona State Retirement System raised its stake in shares of Integral Ad Science by 12.5% during the 4th quarter. Arizona State Retirement System now owns 23,404 shares of the company's stock worth $244,000 after purchasing an additional 2,601 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in shares of Integral Ad Science by 8.9% during the 4th quarter. Victory Capital Management Inc. now owns 32,880 shares of the company's stock valued at $343,000 after buying an additional 2,695 shares during the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 68,671 shares of the firm's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $7.44, for a total value of $510,912.24. Following the completion of the sale, the chief executive officer now owns 334,051 shares in the company, valued at approximately $2,485,339.44. This trade represents a 17.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last quarter, insiders have sold 86,222 shares of company stock worth $636,252. Insiders own 2.00% of the company's stock.

Integral Ad Science Price Performance

NASDAQ IAS traded down $0.07 during trading on Friday, reaching $7.72. 1,389,653 shares of the company traded hands, compared to its average volume of 1,016,187. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The stock's 50 day moving average price is $7.86 and its two-hundred day moving average price is $9.74. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62. The company has a market cap of $1.26 billion, a price-to-earnings ratio of 38.60, a P/E/G ratio of 1.06 and a beta of 1.55.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). The firm had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business's quarterly revenue was up 13.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.06 EPS. As a group, analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on IAS. Barclays dropped their price target on shares of Integral Ad Science from $14.00 to $7.00 and set an "equal weight" rating on the stock in a research note on Monday, April 21st. Scotiabank assumed coverage on Integral Ad Science in a research note on Friday, February 28th. They set a "sector perform" rating and a $12.00 price target for the company. Oppenheimer reissued an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research report on Friday, March 28th. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $13.15.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.